Cell Signaling Technology

Product Pathways - Ca / cAMP / Lipid Signaling

5-Lipoxygenase (C49G1) Rabbit mAb #3289

Applications Reactivity Sensitivity MW (kDa) Isotype
W IP IHC-P H (M) (R) (Mk) Endogenous 78 Rabbit

Applications Key:  W=Western Blotting  IP=Immunoprecipitation  IHC-P=Immunohistochemistry (Paraffin)
Reactivity Key:  H=Human  M=Mouse  R=Rat  Mk=Monkey
Species cross-reactivity is determined by western blot. Species enclosed in parentheses are predicted to react based on 100% sequence homology.

Protocols

Specificity / Sensitivity

5-Lipoxygenase (C49G1) Rabbit mAb detects endogenous levels of total 5-lipoxygenase protein. Expression of 5-Lipoxygenasae is very low in most tissues and cell lines, excepting whole blood, bone marrow, lung and macrophage cell lines.

Source / Purification

Monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Ile168 of human 5-lipoxygenase protein.

Western Blotting

Western Blotting

Western blot analysis of extracts from human RL cells using 5-Lipoxygenase (49G1) Rabbit mAb.

Western Blotting

Western Blotting

Western blot analysis of extracts from COS cells transfected with 5-LO using 5-Lipoxygenase (49G1) Rabbit mAb.

IHC-P (paraffin)

IHC-P (paraffin)

Immunohistochemical analysis of paraffin-embedded non-Hodgkin's lymphoma, using 5-Lipoxygenase (C49G1) Rabbit mAb in the presence of control peptide (left) or antigen specific peptide (right).


Background

5-Lipoxygenase (5-LO, ALOX5) is an important catalytic enzyme responsible for the biosynthesis of leukotriene LTA4 from arachidonic acid (1,2). Leukotriene synthesis also requires 5-lipoxygenase-activating protein (FLAP, ALOX5AP), a nuclear membrane-bound protein that binds arachidonic acid and is thought to activate 5-LO. A number of related leukotrienes (i.e. B4, C4, D4) are derived from LTA4 and together these lipid mediators function in immune reaction regulation. 5-LO is primarily expressed in polymorphonuclear leukocytes, peripheral blood monocytes, macrophages, and mast cells (1,3). Overexpression of 5-LO protein is seen in certain cancer cells and is associated with poor diagnosis (1,4). Depending upon the cell type, 5-LO is localized to either the cytosol or the nucleus of quiescent cells (5). Following stimulation, 5-LO translocates to the nucleus and associates with FLAP to catalyze LTA4 synthesis (2,3). Phosphorylation of specific residues can regulate 5-LO enzymatic activity. Phosphorylation of 5-LO at Ser523 by PKA family kinases inhibits oxygenase activity (6,7) while MAPKAP2 and ERK family kinase phosphorylation at Ser271 and Ser663 stimulates 5-LO enzymatic activity in vivo (8,9).

  1. Woods, J.W. et al. (1995) J Clin Invest 95, 2035-46.
  2. Evans, J.F. et al. (2008) Trends Pharmacol Sci 29, 72-8.
  3. Radmark, O. et al. (2007) Trends Biochem Sci 32, 332-41.
  4. Chen, X. et al. (2006) Curr Cancer Drug Targets 6, 613-22.
  5. Werz, O. (2002) Curr Drug Targets Inflamm Allergy 1, 23-44.
  6. Luo, M. et al. (2004) J Biol Chem 279, 41512-20.
  7. Luo, M. et al. (2005) J Biol Chem 280, 40609-16.
  8. Werz, O. et al. (2002) FASEB J 16, 1441-3.
  9. Werz, O. et al. (2002) J Biol Chem 277, 14793-800.

Application References

Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!

Companion Products

For Research Use Only. Not For Use In Diagnostic Procedures.

Products